Global Strategy Group

Global Strategy Group (GSG) is a leading public affairs, communications, and research firm that provides strategic counsel to major players in the healthcare and life sciences sectors. The firm specializes in navigating complex regulatory environments, managing corporate reputations, and executing data-driven advocacy campaigns for pharmaceutical companies, health systems, and non-profit organizations. GSG is particularly recognized for its expertise in healthcare policy and its ability to translate public opinion research into actionable strategies for industry leaders. In 2022, the firm was acquired by the international strategic communications group SEC Newgate, expanding its global reach while maintaining its focus on the intersection of business and politics. For a biotech analyst, GSG represents a key partner for companies looking to influence the legislative and public perception landscape surrounding drug pricing and market access.